Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome

Area of Science:

• Biochemistry
• Clinical Nutrition
• Human Physiology

Background:

• Chronic Fatigue Syndrome (CFS) is a complex disorder with limited treatment options.
• Mitochondrial dysfunction and oxidative stress are implicated in CFS pathogenesis.
• Ubiquinol-10, the active form of Coenzyme Q10, plays a crucial role in cellular energy production and antioxidant defense.

Purpose of the Study:

• To evaluate the efficacy of oral ubiquinol-10 supplementation in improving symptoms of Chronic Fatigue Syndrome (CFS).
• To assess the benefits of ubiquinol-10 using both an open-label and a randomized, double-blinded, placebo-controlled trial (RCT) design.

Main Methods:

• An 8-week open-label study involving 20 CFS patients receiving 150 mg/day of ubiquinol-10.
• A 12-week randomized, double-blinded, placebo-controlled trial with 43 CFS patients, comparing 150 mg/day ubiquinol-10 to placebo.
• Patient-physician blinding was maintained in the RCT.

Main Results:

• The open-label study indicated beneficial effects of ubiquinol-10.
• The RCT results suggest that 12 weeks of ubiquinol-10 supplementation is effective in improving several CFS symptoms.
• 17 patients completed the ubiquinol group and 14 completed the placebo group in the RCT.

Conclusions:

• Oral ubiquinol-10 supplementation shows promise as a therapeutic option for managing Chronic Fatigue Syndrome.
• Further research may be warranted to confirm these findings and explore optimal dosing and long-term effects.
• Ubiquinol-10 may help alleviate symptoms associated with CFS by addressing potential underlying mechanisms like oxidative stress.